| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.07 |